4.6 Article

Inflammation Induced by Lipopolysaccharide and Palmitic Acid Increases Cholesterol Accumulation via Enhancing Myeloid Differentiation Factor 88 Expression in HepG2 Cells

期刊

PHARMACEUTICALS
卷 15, 期 7, 页码 -

出版社

MDPI
DOI: 10.3390/ph15070813

关键词

lipopolysaccharide; palmitic acid; toll-like receptor 4; myeloid differentiation factor 88; sterol regulatory element-binding protein-2; inflammation; cholesterol accumulation

资金

  1. National Natural Science Foundation of China (NSFC) [81573125, 81872621, 81102130]

向作者/读者索取更多资源

Recent studies have shown that chronic inflammation disrupts cholesterol homeostasis and promotes its accumulation in the liver. This study investigated the relationship between the toll-like receptor 4 (TLR4) inflammatory signaling pathway and cholesterol accumulation. The results revealed that the activation of TLR4/MyD88/NF-kappa B pathway increases SREBP-2-mediated cholesterol accumulation in HepG2 cells.
Recently, multiple studies have shown that chronic inflammation disturbs cholesterol homeostasis and promotes its accumulation in the liver. The underlying molecular mechanism remains to be revealed. The relationship between the toll-like receptor 4 (TLR4) inflammatory signaling pathway and cholesterol accumulation was investigated in HepG2 cells treated with lipopolysaccharide (LPS) or palmitic acid (PA) for different lengths of time. In addition, the effects of pretreatment with 20 mu mol/L ST2825 (MyD88 inhibitor) were also studied in LPS- or PA-treated HepG2 cells and myeloid differentiation factor 88 (MyD88)-overexpressing HEK293T cells. The intracellular total and free cholesterol levels were measured using a commercial kit and filipin staining, respectively. The expression levels of sterol regulatory element-binding protein-2 (SREBP-2) and components in the TLR4 signaling pathway were determined using Western blotting. The treatments with LPS for 12 h and with PA for 24 h significantly increased the contents of intracellular total and free cholesterol, as well as the expression levels of SREBP-2 and components in the TLR4 signaling pathway. The inhibition of MyD88 by ST2825 significantly decreased the cholesterol content and the expression levels of SREBP-2 and components of the TLR4/MyD88/NF-kappa B pathway in HepG2 cells, as well as MyD88-overexpressing HEK293T cells. These results indicated that LPS and PA treatments increase SREBP-2-mediated cholesterol accumulation via the activation of the TLR4/MyD88/NF-kappa B signaling pathway in HepG2 cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据